AI assistant
Sending…
Immuneering Corp — Director's Dealing 2025
Jul 7, 2025
32973_dirs_2025-07-07_4bbb3d0a-d5e3-4910-ae6a-5d1cff2adb14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Immuneering Corp (IMRX)
CIK: 0001790340
Period of Report: 2025-07-02
Reporting Person: HAUSMAN DIANA (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-02 | Class A Common Stock | P | 2500 | $3.5956 | Acquired | 2500 | Direct |
| 2025-07-02 | Class A Common Stock | P | 3000 | $3.6245 | Acquired | 3000 | Indirect |
More from Immuneering Corp
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Director's Dealing
2026
Feb 5
Major Shareholding Notification
2026
Jan 22